Sotera Health Company (NASDAQ:SHC) Stock Has Average Price Target of $21.38 According to Analysts

Shares of Sotera Health Company (NASDAQ:SHC) have been assigned a consensus rating of “Moderate Buy” from the eleven ratings firms that are covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and nine have assigned a buy recommendation to the company. The average 1-year price target among analysts that have covered the stock in the last year is $21.38.

SHC has been the subject of a number of research analyst reports. Barclays increased their target price on shares of Sotera Health from $19.00 to $22.00 and gave the stock an “overweight” rating in a research report on Friday, August 7th. JPMorgan Chase & Co. reissued an “underweight” rating and set a $17.00 target price on shares of Sotera Health in a research report on Wednesday, October 14th. UBS Group set a $19.00 price objective on Sotera Health in a research report on Wednesday, June 24th. Wall Street Zen downgraded Sotera Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Finally, Piper Sandler reissued an “overweight” rating and issued a $25.00 price target on shares of Sotera Health in a report on Tuesday, September 8th.

Sotera Health Price Performance

SHC stock opened at $17.64 on Tuesday. The firm has a 50-day moving average of $18.64 and a two-hundred day moving average of $17.22. Sotera Health has a one year low of $13.09 and a one year high of $19.85. The company has a current ratio of 2.80, a quick ratio of 2.55 and a debt-to-equity ratio of 3.33. The firm has a market capitalization of $5.03 billion, a PE ratio of 30.95 and a beta of 1.85.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.02. Sotera Health had a net margin of 13.44% and a return on equity of 40.12%. The firm had revenue of $321.38 million for the quarter, compared to analysts’ expectations of $309.70 million. During the same period in the previous year, the company posted $0.20 EPS. The company’s quarterly revenue was up 9.2% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. On average, analysts forecast that Sotera Health will post 0.87 earnings per share for the current year.

Insider Buying and Selling at Sotera Health

In other news, Chairman Michael Petras, Jr. sold 850,000 shares of the business’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $18.50, for a total value of $15,725,000.00. Following the transaction, the chairman directly owned 3,969,393 shares of the company’s stock, valued at $73,433,770.50. The trade was a 17.64% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Michael Rutz sold 150,000 shares of the business’s stock in a transaction on Friday, August 7th. The stock was sold at an average price of $18.84, for a total value of $2,826,000.00. Following the completion of the transaction, the insider directly owned 334,279 shares in the company, valued at approximately $6,297,816.36. This represents a 30.97% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 1,294,515 shares of company stock valued at $23,999,528 over the last quarter. Corporate insiders own 15.36% of the company’s stock.

Institutional Trading of Sotera Health

Several hedge funds have recently modified their holdings of the stock. Curated Wealth Partners LLC acquired a new stake in shares of Sotera Health in the 3rd quarter valued at $242,000. Krilogy Financial LLC increased its stake in shares of Sotera Health by 24.9% in the 3rd quarter. Krilogy Financial LLC now owns 17,827 shares of the company’s stock valued at $324,000 after acquiring an additional 3,554 shares during the last quarter. O Keefe Stevens Advisory Inc. raised its holdings in Sotera Health by 4.7% in the third quarter. O Keefe Stevens Advisory Inc. now owns 838,114 shares of the company’s stock worth $15,497,000 after purchasing an additional 37,718 shares during the period. GAMMA Investing LLC raised its stake in Sotera Health by 7.4% during the 3rd quarter. GAMMA Investing LLC now owns 10,055 shares of the company’s stock worth $186,000 after buying an additional 694 shares during the period. Finally, Farther Finance Advisors LLC lifted its holdings in shares of Sotera Health by 20.4% during the 3rd quarter. Farther Finance Advisors LLC now owns 17,770 shares of the company’s stock valued at $329,000 after purchasing an additional 3,009 shares in the last quarter. 91.03% of the stock is owned by institutional investors.

Sotera Health Company Profile

Sotera Health Company (NASDAQ: SHC) is a healthcare services company focused on sterilization, laboratory testing and infection prevention. Its services support manufacturers and providers across the medical device, pharmaceutical, tissue, food safety and other healthcare-related industries.

The company operates through three primary businesses. Sterigenics provides outsourced sterilization services, including ethylene oxide, gamma irradiation and electron-beam processing. Nelson Labs offers laboratory testing, analytical services and consulting for medical devices, pharmaceuticals and other healthcare products.